About CxPM
Dementia can be devastating The CxPM team is devoted to revolutionizing geriatric medicine, one biomarker at a time
Cx Precision Medicine is dedicated to Changing Expectations
Cx Precision Medicine’s technology is licensed from the University of North Texas Health Science Center (UNTHSC) laboratory of Sid O’Bryant, PhD, one of the world’s leading experts in blood-based biomarkers for Alzheimer’s Disease and other neurodegenerative diseases. Dr. O’Bryant is the founder of the company and Professor of Pharmacology and Neuroscience at UNTHSC.
The company’s technology takes the guesswork out of initial diagnoses of neurodegenerative diseases and represents a paradigm shift away from one-size-fits-all treatments to a precision medicine approach, recognizing differences among patients based on their genetics, environment, and lifestyle.
CxPM intellectual properties include 13 issued patents in four patent families.
The CxPM Team
Danguole Altman, MBA
CEO
Carol Berry, MBA
Business Development
Darlene Boudreaux, CPA
CFO
Heather Giles, PhD
COO
Steve Hunsucker, PhD
Lab Operations
Daniel Tessier, PhD
Project Manager
Advisors
Sid O’Bryant, PhD
Scientific Founder & Advisory Board Chair
Valerie Palmieri
Advisory Board Member
Paula Steiner
Advisory Board Member
Jeff Keyser, PhD, RPh, JD
Advisory Board Member
Board of Directors
Danguole Altman
CEO
Bob Ferguson
Chair & Treasurer
Ed Lasater, JD
Secretary
Cameron Cushman
Member
Jeff Keyser, PhD
Member